Trailing-twelve-month (TTM) revenue is $3.07 Billion with a year-over-year growth of +11.22%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-10-31 | $742,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-03 |
| Q4 FY2026Period ended 2026-01-31 | $761,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2027Period ended 2026-04-30 | $765,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-29 |
| Q2 FY2027Period ended 2026-07-31 | $805,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-27 |
| TTM revenue | $3,073,000,000 |
Current P/S: $28,695,568,800 market capitalization ÷ $3,073,000,000 TTM revenue = 9.34x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-07-31): $805.00M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Subscription and Circulation | $797M | $1.2B | $1.8B | $2.2B | $2.6B | $2.9B |
| Technology Service | $39M | $51M | $64M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $134M | $264M | $402M | $480M | $548M | $598M |
| UNITED STATES | $702M | $1.0B | $1.5B | $1.8B |
$3.07B
$3.07 Billion
+11.22%
vs. $2.76B a year ago (TTM)
+24.72%
5 Year compound annual growth rate
1 Year
+11.22%
3 Year
+14.16%
5 Year
+24.72%
10 Year
+38.33%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.92B | +$309.00M | +11.84% |
| 2025 | $2.61B | +$347.00M | +15.33% |
| 2024 | $2.26B | +$405.00M | +21.80% |
| 2023 | $1.86B | +$558.00M | +42.92% |
| 2022 | $1.30B | +$465.00M | +55.69% |
| 2021 |
TTM Growth
+11.22%
3-Year CAGR
+14.16%
5-Year CAGR
+24.72%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 39 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $54M |
| $64M |
| $2.3B |
| $835.00M |
| +$248.93M |
| +42.48% |
| 2020 | $586.07M | +$186.81M | +46.79% |
| 2019 | $399.25M | +$142.71M | +55.63% |
| 2018 | $256.55M | +$95.74M | +59.54% |
| 2017 | $160.81M | +$74.90M | +87.19% |
